A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery
Completed · Phase 1 · Has a placebo group
Conditions studied: Injury of Kidney, Acute Renal Failure
In brief
This is a Phase 1, randomized, double-blind, dose escalation, safety and pharmacokinetic study. The study will be conducted in approximately 8-10 centers in the United States and Switzerland. Up to 32 patients who have undergone major cardiovascular surgery will participate. Patients will receive a single IV injection of I5NP or placebo following cardiovascular surgery. I5NP will be administered 4 hours (+/- 30 minutes) following removal of the cardiopulmonary bypass machine (CBM). The duration of the study is approximately 44 days, inclusive of a 14 day screening period. Patients will be contacted by phone at 6 and 12 months for follow-up questions. Patient visits are screening, day of surgery, hospital in-patient Days 1, 2, 3 and Day 7 or hospital discharge. Safety follow-up will continue until 30 days post-surgery. 2 phone calls will be made at 6 and 12 months after date of surgery.
Key facts
- Study ID
- NCT00554359
- Run by
- Quark Pharmaceuticals
- People needed
- 16
- Starts
- 2007-08-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2011-02-23
Who can join
Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- George Washington University — Washington D.C., District of Columbia, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Texas Heart Institute at St. Luke's Episcopal Hospital — Houston, Texas, United States
- University of Virginia School of Medicine — Charlottesville, Virginia, United States
- Shaare Zedek Medical Center — Jerusalem, Israel
- Rabin Medical Center — Petah Tikva, Israel
- Tel Aviv Sourasky Medical Center — Tel Aviv, Israel
- University Hospital of Geneva — Geneva, Switzerland
- Lausanne University Hospital (CHUV) — Lausanne, Switzerland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.